MSBA-S – A pentacyclic sulfamate as a new option for radiotherapy of human breast cancer cells

Volume: 224, Pages: 113721 - 113721
Published: Nov 1, 2021
Abstract
Many pentacyclic triterpenoids show anti-cancer and anti-inflammatory properties. Recently, we detected a pronounced cytotoxicity and radiosensitivity of two betulinyl sulfamates in human breast cancer cells. Besides betulinic acid scaffold (BSBA-S), we synthesized several new sulfamate-coupled scaffolds from oleanolic acid (OSBA-S), ursolic acid (USBA-S), platanic acid (PSBA-S) and maslinic acid (MSBA-S). Highest cytotoxicity was monitored in...
Paper Details
Title
MSBA-S – A pentacyclic sulfamate as a new option for radiotherapy of human breast cancer cells
Published Date
Nov 1, 2021
Volume
224
Pages
113721 - 113721
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.